CPC Scientific Inc.
John Phipps is an experienced professional in the biopharmaceutical industry, currently serving as the Vice President of Clinical Pipeline Development U.S. and previously as Senior Director of Business Development at CPC Scientific Inc., a leading Contract Development & Manufacturing Organization specializing in peptide production. Earlier roles include Business Development Executive at Exova Health Sciences and Bachem, Business Development Manager at New England Peptide, and President/Owner at Global Peptide Services. John also served as Manager at the Macromolecular Resource Facility. John Phipps holds a B.S. in Biochemistry from Colorado State University, completed in 1992.
This person is not in any offices
CPC Scientific Inc.
1 followers
With over 20 years of experience, CPC Scientific is a global CRDMO specializing in peptides and oligonucleotides. Our integrated service model supports partners through critical drug development stages, focusing on late-phase, large-scale, and commercial production. We provide GMP-grade synthetic peptides, oligonucleotides, and peptide-oligonucleotide conjugates, plus a wide range of custom and catalog research products. Our FDA- and ICH-compliant GMP facility ensures regulatory support for IND, NDA, and global filings. We offer process and method development, validation, stability studies, and regulatory documentation to accelerate your program from clinical trials to market. With scalable capacity from milligrams to 100 kilograms, flexible infrastructure, and a robust supply chain, CPC Scientific delivers dependable, high-quality results at every phase, providing the expertise and speed to bring your peptide and oligonucleotide programs to successful commercial production.